SCHEMBL23317208

SCHEMBL23317208

CCCC(C(=O)Nc1c(C)cccc1C)[PH](CC)(CC)CC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.43
HSP90AA1 P07900 1/20 0.43
LMNA P02545 4/20 0.43
MAPT P10636 3/20 0.43
SCN3A Q9NY46 3/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
SCN1A P35498 2/20 0.43
SCN2A Q99250 2/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2C9 P11712 2/20 0.43
MAPK1 P28482 2/20 0.43
ALDH1A1 P00352 2/20 0.43
CYP3A4 P08684 2/20 0.43
MC4R P32245 1/20 0.43
SCN4A P35499 1/20 0.43
MC3R P41968 1/20 0.43
HTR3A P46098 1/20 0.43
SCN5A Q14524 1/20 0.43
SCN9A Q15858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23317239 0.91 MEN1 (0.45) ATMHSP90AA1LMNAMAPTSCN3A
SCHEMBL23294937 0.88 ATM (0.46) ATMHSP90AA1LMNAMAPTSCN3A
SCHEMBL23317287 0.87 ATM (0.41) ATMHSP90AA1LMNAMAPTSCN3A
SCHEMBL23317314 0.87 ATM (0.44) ATMHSP90AA1LMNAMAPTSCN3A
SCHEMBL23317704 0.85 LMNA (0.40) LMNAMAPTSCN3AMEN1KMT2A
Bicarbonate SCHEMBL23294944 0.85 ATM (0.47) ATMHSP90AA1LMNAMAPTSCN3A
SCHEMBL23317396 0.85 LMNA (0.43) LMNAMEN1KMT2ACYP2C9ALDH1A1
SCHEMBL23317336 0.83 PSEN1 (0.34) LMNACYP2C9ALDH1A1GAANLRP3
SCHEMBL23317659 0.83 CA1 (0.37) LMNACYP2C9MAPK1GAAL3MBTL1
SCHEMBL23317171 0.80 ATM (0.50) ATMHSP90AA1LMNAMAPTSCN3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11701370-B2 Phosphonium ion channel blockers and methods for use Nocion Therapeutics, Inc. (US) 2023-07-18 US disclosed
US-11701370-B2 Phosphonium ion channel blockers and methods for use Nocion Therapeutics, Inc. (US) 2023-07-18 US disclosed
US-20210128589-A1 PHOSPHONIUM ION CHANNEL BLOCKERS AND METHODS FOR USE Nocion Therapeutics, Inc. 2021-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210128589-A1 PHOSPHONIUM ION CHANNEL BLOCKERS AND METHODS FOR USE TRPV1, TRPV5, TRPA1 ATM 4286/4885HSP90AA1 3207/4885LMNA 3757/4885
US-11701370-B2 Phosphonium ion channel blockers and methods for use TRPV1, TRPV5, TRPA1 ATM 4286/4885HSP90AA1 3207/4885LMNA 3757/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.